Skip to content

Insider · CIK 0001636357

Alan M Hoberman

director

Files at BIXT (BIOXYTRAN, INC). First filing Nov 18, 2025, latest Nov 18, 2025.

In brief

Alan M Hoberman files SEC Form 4 as director at BIXT (BIOXYTRAN, INC). Since Nov 18, 2025, Alan M Hoberman has reported 1 open-market buy worth $126k and 0 open-market sells worth $0, the latest filed on Nov 18, 2025.

A track record needs three past buys with six months of prices behind them; Alan M Hoberman has 0, so none is measured yet.

The newest scored trade: bought $126k of BIXT on Nov 18, 2025, filed Nov 18, 2025, scored 34 (weak). In the last 12 months: 1 buy worth $126k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$126k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BIXT: BIOXYTRAN, INC

BIXTOct 9, 2026 · close 0.02

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
34Weak
BIXTbuy
BIOXYTRAN, INC
$126k
210,000 shares
--

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 12, 2025BIXT
BIOXYTRAN, INC
AGrant or award
preferred
+10,417$0.49$5,052377,619Nov 18, 2025
Nov 14, 2025BIXT
BIOXYTRAN, INC
AGrant or award
preferred
+38,588$0.35$14k416,207Nov 18, 2025
Nov 18, 2025BIXT
BIOXYTRAN, INC
POpen-market purchase
common
+210,000$0.60$126k210,000Nov 18, 2025
Jan 6, 2025BIXT
BIOXYTRAN, INC
AGrant or award
Preferred
+97,535$0.32$31k367,202Jan 14, 2025
Oct 25, 2024BIXT
BIOXYTRAN, INC
AGrant or award
preferred
+20,619$0.46$9,485269,667Oct 28, 2024

Questions about Alan M Hoberman

Answered from the filings on this page, as of the latest one.

Is Alan M Hoberman buying or selling?

In the last 12 months Alan M Hoberman reported 1 open-market buy worth $126k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $126k of BIXT on Nov 18, 2025. Grants, option exercises and tax withholding are not counted.

How did Alan M Hoberman's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alan M Hoberman has 0.

Where does Alan M Hoberman file Form 4?

Alan M Hoberman has filed Form 4 at BIXT (BIOXYTRAN, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Alan M Hoberman: insider trades and track record | InsiderTell